Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
The state-of-the-art facility is equipped with best-in-class equipment and control systems
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Automated parallel capillary electrophoresis system simplifies protein analysis
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Subscribe To Our Newsletter & Stay Updated
